Novartis: Tabuthema metastasierter Brustkrebs: Krankheit als Schuld, neue Therapieoptionen und Wege aus der Sprachlosigkeit

Rückfragheinweis
Mag. Sabine Reinprecht
Head of Communications & Patient Relations Novarits Oncology
Tel: +43 (0)1 86657 6311
Mobil: +43 (0)664 8278610
Email: sabine.reinprecht(at)novartis.com

Ilda Sabanovic, MSc.
Communications Manager
Tel: +43 (0)1 86657 6011
Mobil: +43 (0)664 4323369
Email: ilda.sabanovic(at)novartis.com

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.